Clinical trials

Filters
Clear filters
1,718 trials
TrialSponsorPhaseStatusPrimary completion
Study of AT-752 in Patients With Dengue InfectionNCT05466240AVIRPhase 2Terminated2023-01-19Actual
Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)NCT05466890PTNPhase 2Active not recruiting2025-02-10Actual
Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 YearsNCT05468736NovavaxPhase 2, Phase 3Completed2024-01-16Actual
A Study to Evaluate LB1148 for Return of Bowel Function in Subjects Undergoing Bowel ResectionNCT05470387Palisade BioPhase 3Terminated2023-03-06Actual
A Phase 2 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Patients With Multi-Site Pain Associated With Post-Acute Sequelae of SARS-CoV-2 InfectionNCT05472090Tonix Pharmaceuticals, Inc.Phase 2Completed2023-07-12Actual
A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in RemissionNCT05479058LKFTPhase 3Terminated2023-10-09Actual
Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept StudyNCT05481736COMPASS PathwaysPhase 2Completed2024-11-18Actual
A Study of Vatiquinone for the Treatment of Participants With Friedreich AtaxiaNCT05485987PTC TherapeuticsPhase 2Completed2024-08-29Actual
A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS)NCT05490446AGIOPhase 2Active not recruiting2026-03-17Actual
Ampligen Combined With SOC Versus SOC Alone Following First-Line Therapy in Subjects With LAPCNCT05494697AIMPhase 2Suspended2031-02Estimated
Impact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot)NCT05494788CRDLPhase 2Completed2024-06-15Actual
A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SPR720 as Compared With Placebo for the Treatment of Participants With Mycobacterium Avium Complex (MAC) Pulmonary DiseaseNCT05496374Spero TherapeuticsPhase 2Completed2024-10-08Actual
Safety and Efficacy of Intranasal Epinephrine After Administration of ARS -1 in Subjects With Frequent Urticaria FlaresNCT05496465SPRYPhase 2Completed2024-02-29Actual
A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)NCT05500222MDGLPhase 3Active not recruiting2026-12Estimated
Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)NCT05501886CELCPhase 3Active not recruiting2026-06-30Estimated
A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)NCT05506943Compass TherapeuticsPhase 2, Phase 3Active not recruiting2027-08-31Estimated
ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1NCT05507203ABVXPhase 3Completed2025-06-24Actual
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2NCT05507216ABVXPhase 3Completed2025-06-24Actual
Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)NCT05509023QTTBPhase 2Active not recruiting2024-12Estimated
Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic ArthritisNCT05511519ACRSPhase 2Terminated2023-12-06Actual
A Study of CTX-009 in Adult Patients With Metastatic Colorectal CancerNCT05513742Compass TherapeuticsPhase 2Completed2025-05-15Actual
A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With Friedreich AtaxiaNCT05515536PTC TherapeuticsPhase 3Active not recruiting2027-12-31Estimated
Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant EpilepsyNCT05518578SUPNPhase 2Recruiting2027-12-31Estimated
A Study to Evaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination VaccineNCT05519839NovavaxPhase 2Completed2023-07-25Actual
Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton SyndromeNCT05521438Quoin PharmaceuticalsPhase 2, Phase 3Active not recruiting2025-12-30Actual
An Open-Label Extension of XPro1595 in Patients With Alzheimer's DiseaseNCT05522387INMBPhase 2Terminated2024-06-05Actual
Pimavanserin for the Treatment of Irritability Associated With Autism Spectrum DisorderNCT05523895ACADPhase 2, Phase 3Completed2024-09-27Actual
Study for Adolescents and Adults With Ornithine Transcarbamylase Deficiency to Evaluate Safety and Tolerability of ARCT-810NCT05526066Arcturus Therapeutics, Inc.Phase 2Terminated2024-10-31Actual
A Study of Botensilimab (AGEN1181) for the Treatment of Advanced MelanomaNCT05529316AGENPhase 2Terminated2026-04-27Actual
A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's DiseaseNCT05531656Cognition TherapeuticsPhase 2Active not recruiting2027-05-31Estimated

Primary completion marks the end of data collection for the main study measures, not a results publication date.